Cargando…
Structures suggest an approach for converting weak self-peptide tumor antigens into superagonists for CD8 T cells in cancer
Tumors frequently express unmutated self-tumor–associated antigens (self-TAAs). However, trial results using self-TAAs as vaccine targets against cancer are mixed, often attributed to deletion of T cells with high-affinity receptors (TCRs) for self-TAAs during T cell development. Mutating these weak...
Autores principales: | Wei, Pengcheng, Jordan, Kimberly R., Buhrman, Jonathan D., Lei, Jun, Deng, Hexiang, Marrack, Philippa, Dai, Shaodong, Kappler, John W., Slansky, Jill E., Yin, Lei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
National Academy of Sciences
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8201969/ https://www.ncbi.nlm.nih.gov/pubmed/34074778 http://dx.doi.org/10.1073/pnas.2100588118 |
Ejemplares similares
-
C-terminal modification of the insulin B:11–23 peptide creates superagonists in mouse and human type 1 diabetes
por: Wang, Yang, et al.
Publicado: (2018) -
Improving Antigenic Peptide Vaccines for Cancer Immunotherapy Using a Dominant Tumor-specific T Cell Receptor
por: Buhrman, Jonathan D., et al.
Publicado: (2013) -
Mimotope vaccine efficacy gets a "boost" from native tumor antigens
por: Buhrman, Jonathan D., et al.
Publicado: (2013) -
Selection of Antigen-specific T Cells by a Single IE(k) Peptide Combination
por: Liu, Chih-Pin, et al.
Publicado: (1997) -
TCR hypervariable regions expressed by T cells that respond to effective tumor vaccines
por: Jordan, Kimberly R., et al.
Publicado: (2012)